Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Research urgently needed to treat blood clots in children


Potentially deadly blood clots are being missed in children, and more research and awareness is needed in the medical community, according to a study done in part at the University of Alberta.

"We don’t think of blood clots occurring in children, but they do," said Dr. Patricia Massicotte, a professor of pediatrics at the University of Alberta, and one of the study’s authors.

A review of treatments for pulmonary thromboembolism (PTE) in children, conducted by the University of Alberta, the Edmonton Stollery Children’s Hospital and The Hospital for Sick Children in Toronto, revealed an acute need for more research into diagnosing the condition, whose symptoms can be misleading.

Review of data on 405 children who died in specialized pediatric hospitals in Canada between 1991-97 revealed that three per cent of the deaths were attributable to blood clots. "The condition does kill and it can also cause long-term cardiac problems or respiratory problems," Dr. Massicotte said.

The review results appear in the March, 2005 issue of Pediatric Radiology.

The condition, which exists in children ranging from premature infants to the late teens, is often not discovered until the autopsy stage. PTE most frequently exists in children who suffer from underlying conditions such as heart disease or cancer. Blood clots can be brought on by several risk factors and causes including burns, heart disease, dehydration, obesity, renal disease, shock and surgery.

One of the highest risk factors for blood clots in children is a central venous line, a large catheter inserted into the body to administer medication or nutrients. The line can damage vessel walls. But at the same time, the line is needed to help care for children suffering illness or trauma, and that makes recognizing the symptoms of PTE all the more vital, Dr. Massicotte said.

While the causes of blood clots in 30 to 40 per cent of adults have unknown origins, to their surprise, the researchers discovered in the review that only four per cent of the clots in children presented without any risk factors, Dr. Massicotte noted.

"The other 96 per cent had at least two or more known risk factors. The expert care centres (pediatric hospitals) know that children develop blood clots, but there are a lot of other health professionals who still don’t recognize the signs and symptoms."

Further research is needed, exploring such options as smaller catheters for pediatric patients, as well as clinical trials in using blood-thinners as preventive therapy. Currently, thinners are used only after a child develops clots.

Traditionally, researching more invasive treatment options for children has been regarded with reluctance, Dr. Massicotte said. "Because babies and children are so cute and innocent, we are reluctant to do studies, but we are not benefiting them at all by doing that."

Bev Betkowski | EurekAlert!
Further information:

More articles from Health and Medicine:

nachricht NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases

nachricht Researchers identify key step in viral replication
13.03.2018 | University of Pittsburgh Schools of the Health Sciences

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Mars' oceans formed early, possibly aided by massive volcanic eruptions

Oceans formed before Tharsis and evolved together, shaping climate history of Mars

A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...

Im Focus: Tiny implants for cells are functional in vivo

For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.

In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...

Im Focus: Locomotion control with photopigments

Researchers from Göttingen University discover additional function of opsins

Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...

Im Focus: Surveying the Arctic: Tracking down carbon particles

Researchers embark on aerial campaign over Northeast Greenland

On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...

Im Focus: Unique Insights into the Antarctic Ice Shelf System

Data collected on ocean-ice interactions in the little-researched regions of the far south

The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

Latest News

Physicists made crystal lattice from polaritons

20.03.2018 | Physics and Astronomy

Mars' oceans formed early, possibly aided by massive volcanic eruptions

20.03.2018 | Physics and Astronomy

Thawing permafrost produces more methane than expected

20.03.2018 | Earth Sciences

Science & Research
Overview of more VideoLinks >>>